DK1300160T3 - Fremgangsmåde til stabilisering af en sammensætning - Google Patents

Fremgangsmåde til stabilisering af en sammensætning

Info

Publication number
DK1300160T3
DK1300160T3 DK01932213.0T DK01932213T DK1300160T3 DK 1300160 T3 DK1300160 T3 DK 1300160T3 DK 01932213 T DK01932213 T DK 01932213T DK 1300160 T3 DK1300160 T3 DK 1300160T3
Authority
DK
Denmark
Prior art keywords
stabilizing
composition
Prior art date
Application number
DK01932213.0T
Other languages
English (en)
Inventor
Tadashi Mukai
Minoru Kashimoto
Masakazu Nagasawa
Daisuke Kuribayashi
Yoshikazu Oka
Hajime Toguchi
Yuso Tomohira
Tetsuroh Ichiba
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK1300160T3 publication Critical patent/DK1300160T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01932213.0T 2000-05-24 2001-05-23 Fremgangsmåde til stabilisering af en sammensætning DK1300160T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000152969 2000-05-24
PCT/JP2001/004302 WO2001089573A1 (fr) 2000-05-24 2001-05-23 Procede servant a stabiliser une preparation

Publications (1)

Publication Number Publication Date
DK1300160T3 true DK1300160T3 (da) 2014-03-24

Family

ID=18658308

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01932213.0T DK1300160T3 (da) 2000-05-24 2001-05-23 Fremgangsmåde til stabilisering af en sammensætning

Country Status (13)

Country Link
US (1) US7867514B2 (da)
EP (1) EP1300160B1 (da)
JP (1) JP4902928B2 (da)
KR (1) KR100741937B1 (da)
CN (1) CN100377746C (da)
AU (1) AU5881001A (da)
CA (1) CA2408796C (da)
CY (1) CY1115023T1 (da)
DK (1) DK1300160T3 (da)
ES (1) ES2461196T3 (da)
HK (1) HK1055675A1 (da)
PT (1) PT1300160E (da)
WO (1) WO2001089573A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043704A1 (en) 2000-12-01 2002-06-06 Kyowa Hakko Kogyo Co., Ltd. Composition improved in solubility or oral absorbability
KR101220643B1 (ko) * 2006-08-16 2013-01-14 알리코제약(주) 사포그릴레이트 함유 경구투여 형태의 약제
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
EP3409294A1 (en) 2017-06-01 2018-12-05 Przedsiebiorstwo Farmaceutyczne Lek-Am Sp Z O. O. Tablets containing cilostazol of specific particle size distribution
JP7233852B2 (ja) * 2018-04-17 2023-03-07 キョーリンリメディオ株式会社 変色が抑制された固形製剤
AR121187A1 (es) * 2019-12-27 2022-04-27 Chugai Pharmaceutical Co Ltd Método para clasificar, evaluar o fabricar lauril sulfato de sodio de materia prima o formulación farmacéutica que lo contiene
US11718753B2 (en) 2020-05-28 2023-08-08 Ethicon, Inc. Topical skin closure compositions and systems
CN115212206B (zh) * 2022-08-15 2023-04-18 江苏知原药业股份有限公司 一种含吡非尼酮的药物组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168478A (en) * 1960-07-28 1965-02-02 Gen Aniline & Film Corp Highly alkaline surface active compositions
JPS6019715A (ja) * 1983-07-12 1985-01-31 Nisshin Flour Milling Co Ltd 安定なイソカルボスチリル製剤
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
AU4513393A (en) * 1992-07-17 1994-02-14 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
EG20321A (en) * 1993-07-21 1998-10-31 Otsuka Pharma Co Ltd Medical material and process for producing the same
JP3486930B2 (ja) * 1993-09-10 2004-01-13 ライオン株式会社 口腔用組成物
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
TW412425B (en) * 1994-10-18 2000-11-21 Kao Corp Dentifrice composition having capsule particles
US5817337A (en) * 1995-10-06 1998-10-06 Desenna; Richard A. Disinfectant effervescent tablet formulation
ATE271863T1 (de) * 1995-11-14 2004-08-15 Abbott Gmbh & Co Kg Schilddrüsenhormone enthaltende stabilisierte arzneimittel und verfahren
CA2259298A1 (en) * 1996-07-01 1998-01-08 Pfizer Inc. Virginiamycin mixture
JPH10130142A (ja) 1996-10-31 1998-05-19 Zensei Yakuhin Kogyo Kk 放出持続型圧縮製剤
JP3618205B2 (ja) * 1997-10-09 2005-02-09 サンスター株式会社 泡沫状フッ素塗布剤
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
JP4221068B2 (ja) * 1997-12-17 2009-02-12 興和創薬株式会社 テオフィリン徐放性錠剤及びその製造方法
JPH11189546A (ja) * 1997-12-25 1999-07-13 Saitama Daiichi Seiyaku Kk 経皮吸収促進剤
JPH11189531A (ja) * 1997-12-26 1999-07-13 Dai Ichi Seiyaku Co Ltd 経粘膜投与用医薬組成物
GB9804648D0 (en) * 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
US6187790B1 (en) * 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6121271A (en) * 1998-05-12 2000-09-19 American Home Products Corporation Naphtho[2,3-B]heteroar-4-yl derivatives
NZ508544A (en) * 1998-06-05 2002-10-25 Warner Lambert Co Angiotensin converting enzyme inhibitors, such as quinapril, enalapril and indolapril, stabilised with 1-90 wt% magnesium oxide
EG23951A (en) * 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
US6451813B1 (en) * 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups

Also Published As

Publication number Publication date
CN1430520A (zh) 2003-07-16
CY1115023T1 (el) 2016-12-14
KR100741937B1 (ko) 2007-07-24
CN100377746C (zh) 2008-04-02
HK1055675A1 (en) 2004-01-21
EP1300160B1 (en) 2014-03-12
PT1300160E (pt) 2014-05-02
AU5881001A (en) 2001-12-03
CA2408796C (en) 2009-12-15
KR20030009498A (ko) 2003-01-29
EP1300160A1 (en) 2003-04-09
EP1300160A4 (en) 2009-07-29
CA2408796A1 (en) 2002-11-15
JP4902928B2 (ja) 2012-03-21
ES2461196T3 (es) 2014-05-19
WO2001089573A1 (fr) 2001-11-29
US7867514B2 (en) 2011-01-11
US20030161873A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1312239T3 (da) Teknikker til undertrykkelse af interferens
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1364057T3 (da) Fremgangsmåde til detektion af ligander
DK1257954T3 (da) Fremgangsmåde til fordeling af forsendelser
DK1317181T3 (da) Fremgangsmåde til fremstilling af en herbicid faststofformulering
DK1575416T3 (da) Fremgangsmåder til diagnosticering af præeklampsi
DK1293507T3 (da) Fremgangsmåde til fremstilling af krystaller
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1619192T3 (da) Arylkondeserede azapolycykliske forbindelser
DK2135957T3 (da) Fremgangsmåde til fremstilling af glucaner
DE60029553D1 (de) Schätzungsmethode
DK1330370T3 (da) Fremgangsmåde til fremstilling af overfladeelementer
DE60103427D1 (de) Übereinstimmungssteuerverfahren
DK1349580T3 (da) Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning
DK1230247T3 (da) Fremgangsmåde til stabilisering af siloxanforbindelser
FI20002824A (fi) Menetelmä puhelun muodostamiseksi
DE50112555D1 (de) Sensorloses Ansteuerverfahren
DK1217316T3 (da) Fremgangsmåde til styring af en kölecyklus
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1300160T3 (da) Fremgangsmåde til stabilisering af en sammensætning
ATE372338T1 (de) Deshalogenverbindungen
NO20030303L (no) Kalsilytiske forbindelser
NO20031837L (no) Kalsilytiske forbindelser
NO20023508L (no) Kalsilyttiske forbindelser